Abstract: A semiconductor laser device includes an optical waveguide that extends toward a first end of the semiconductor laser device. The optical waveguide includes a first clad layer, an active layer, a second clad layer, and an electrode layer in this order. A reflecting surface, which has a dielectric film and a metal film in this order from the active layer, crosses the active layer at a second end of the optical waveguide.

Abstract: A pharmacotherapy is provided for preventing glaucoma or preventing or treating ocular hypertension, the pharmacotherapy providing potent intraocular pressure-lowering action with fast-acting properties and prolonged duration. A combination of (S)-(?)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine or a salt thereof, or a solvate of (S)-(?)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine or the salt thereof and an ?2 agonist for preventing or treating glaucoma.

Abstract: A pharmacotherapy is provided for preventing glaucoma or preventing or treating ocular hypertension, the pharmacotherapy providing potent intraocular pressure-lowering action with fast-acting properties and prolonged duration. A combination of (S)-(?)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine or a salt thereof, or a solvate of (S)?)-1-(4-fluoro-S-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine or the salt thereof and an ?2 agonist for preventing or treating glaucoma.

Abstract: A light emitting device which emits a secondary light with high color purity and has a fast response speed is obtained. A KSF phosphor (15) which absorbs a part of blue light and emits red light and a CASN phosphor (16) are distributed in a resin (14) which seals an LED chip (13) which emits the blue light. The KSF phosphor (15) absorbs the blue light and emits the red light by forbidden transition, and the CASN phosphor (16) absorbs the blue light and emits the red light by allowed transition.

Abstract: Upon evaluation of a value of a diagnostic process, the value of a diagnostic process is evaluated not based on a simple cost but on a cost required for all processes of a patient who was in the diagnostic process through a follow-up survey. Diagnostic processes that are not relevant to a target diagnostic process are eliminated, clustering is performed on patients to divide the patients into clinically meaningful homogeneous groups, and the target diagnostic process is evaluated for each of the homogeneous groups. For the purpose, importance scores of data pieces of the clinical data are calculated and the relevant data is output using the output result of the medical knowledge extraction unit, clustering is performed on patients in the clinical data, and a clinical index and a cost are output for each of the clusters.

Abstract: A semiconductor laser device includes an optical waveguide that extends toward a first end of the semiconductor laser device. The optical waveguide includes a first clad layer, an active layer, a second clad layer, and an electrode layer in this order. A reflecting surface, which has a dielectric film and a metal film in this order from the active layer, crosses the active layer at a second end of the optical waveguide.

Abstract: A light emitting device which emits a secondary light with high color purity and has a fast response speed is obtained. A KSF phosphor (15) which absorbs a part of blue light and emits red light and a CASN phosphor (16) are distributed in a resin (14) which seals an LED chip (13) which emits the blue light. The KSF phosphor (15) absorbs the blue light and emits the red light by forbidden transition, and the CASN phosphor (16) absorbs the blue light and emits the red light by allowed transition.

Abstract: A light emitting device which emits a secondary light with high color purity and has a fast response speed is obtained. A KSF phosphor (15) which absorbs a part of blue light and emits red light and a CASN phosphor (16) are distributed in a resin (14) which seals an LED chip (13) which emits the blue light. The KSF phosphor (15) absorbs the blue light and emits the red light by forbidden transition, and the CASN phosphor (16) absorbs the blue light and emits the red light by allowed transition.

Abstract: A pharmacotherapy is provided for preventing glaucoma or preventing or treating ocular hypertension, the pharmacotherapy providing potent intraocular pressure-lowering action with fast-acting properties and prolonged duration. A combination of (S)-(?)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine or a salt thereof, or a solvate of (S)-(?)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine or the salt thereof and an ?2 agonist for preventing or treating glaucoma.

Abstract: The present invention provides a method for the prevention and treatment of complications after cataract surgery such as secondary cataract and anterior capsule contraction that occur after cataract operation. The present invention relates to a preventive/therapeutic method comprising administering to a subject a medicine containing 4-fluoro-5-{[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl}isoquinoline (Ripasudil) or a salt thereof, or a solvate thereof as an active ingredient.

Abstract: A light emitting device which emits a secondary light with high color purity and has a fast response speed is obtained. A KSF phosphor (15) which absorbs a part of blue light and emits red light and a CASN phosphor (16) are distributed in a resin (14) which seals an LED chip (13) which emits the blue light. The KSF phosphor (15) absorbs the blue light and emits the red light by forbidden transition, and the CASN phosphor (16) absorbs the blue light and emits the red light by allowed transition.

Abstract: A light emitting device includes: a substrate having a main surface; a phosphor layer provided on the main surface and containing an LED element that emits primary light and a fluorescent particle that absorbs a part of the primary light and emits secondary light; and a transparent resin layer having a refractive index n and covering the phosphor layer. The transparent resin layer has an outer circumferential surface that forms a boundary between the transparent resin layer and the atmosphere. When a minimum circumference that includes the overall phosphor layer and is concentric with the outer circumferential surface has a radius r in a cut surface where at least a part of the outer circumferential surface takes a shape of an arc having a radius R, a relationship of R>r·n is satisfied. With such configuration, the light extraction efficiency is enhanced.

Abstract: A light emitting device which emits a secondary light with high color purity and has a fast response speed is obtained. A KSF phosphor (15) which absorbs a part of blue light and emits red light and a CASN phosphor (16) are distributed in a resin (14) which seals an LED chip (13) which emits the blue light. The KSF phosphor (15) absorbs the blue light and emits the red light by forbidden transition, and the CASN phosphor (16) absorbs the blue light and emits the red light by allowed transition.

Abstract: The present invention provides a method for the prevention and treatment of complications after cataract surgery such as secondary cataract and anterior capsule contraction that occur after cataract operation. The present invention relates to a preventive/therapeutic method comprising administering to a subject a medicine containing 4-fluoro-5-{[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl}isoquinoline (Ripasudil) or a salt thereof, or a solvate thereof as an active ingredient.

Abstract: Improves light extraction efficiency. A light emitting device 1 using a white resin molding package 5 integrally molded with lead frames 3, 4 constituting an electrode corresponding to one or a plurality of light emitting element 2 and white resin, wherein an area in a plane view of a white resin surface on a reflective surface that is level with amounting surface of the light emitting element 2 is configured to be larger than total area in a plane view occupied by surfaces of the lead frames 3, 4 and the light emitting element. Further, a step section is formed on the surfaces of lead frames 3, 4, white resin is filled in the step section, and the area of white resin surface on a reflective surface where the light emitting element 2 is mounted is increased.

Abstract: A light emitting device which emits a secondary light with high color purity and has a fast response speed is obtained. A KSF phosphor (15) which absorbs a part of blue light and emits red light and a CASN phosphor (16) are distributed in a resin (14) which seals an LED chip (13) which emits the blue light. The KSF phosphor (15) absorbs the blue light and emits the red light by forbidden transition, and the CASN phosphor (16) absorbs the blue light and emits the red light by allowed transition.

Abstract: A method for manufacturing a light-emitting device, the method comprising: a frame formation step of forming a frame such that a height from a surface of a terminal to which a wire is connected to an upper rim of the frame is smaller than a height from a top surface of a light-emitting element to the upper rim of the frame; a bump formation step of forming a bump on an electrode of the light-emitting element to which the wire is connected; a first bonding step of bonding, first, one end of the wire to the terminal; a second bonding step of bonding, subsequently, the other end of the wire to the bump; and a sealing step of sealing the light-emitting element by filling a sealing material inside the frame.

Abstract: Upon evaluation of a value of a diagnostic process, the value of a diagnostic process is evaluated not based on a simple cost but on a cost required for all processes of a patient who was in the diagnostic process through a follow-up survey. Diagnostic processes that are not relevant to a target diagnostic process are eliminated, clustering is performed on patients to divide the patients into clinically meaningful homogeneous groups, and the target diagnostic process is evaluated for each of the homogeneous groups. For the purpose, importance scores of data pieces of the clinical data are calculated and the relevant data is output using the output result of the medical knowledge extraction unit, clustering is performed on patients in the clinical data, and a clinical index and a cost are output for each of the clusters.

Abstract: An LED classification device (21) classifies LEDs, the LEDs each including a combination of an LED element that emits a primary light and a phosphor that, upon excitation by the primary light, emits a secondary light having a longer wavelength than the primary light, the LEDs each emitting a combined light of the primary light and the secondary light, those ones of the LEDs whose primary lights having their chromaticities falling within a predetermined chromaticity range being classified as LEDs for use in a backlight of a liquid crystal display apparatus. A coefficient calculating section (26) and a corrected chromaticity calculating section (27) calculate, for all of the LEDs to be classified, correction values for the chromaticities as obtained on the assumption that the primary lights have traveled through a color filter of the liquid crystal display apparatus, and correct chromaticities by subtracting the correction values from chromaticities obtained for all of the LEDs to be classified, respectively.

Abstract: An LED classification device classifies LEDs, the LEDs each including a combination of an LED element that emits a primary light and a phosphor that, upon excitation by the primary light, emits a secondary light having a longer wavelength than the primary light, the LEDs each emitting a combined light of the primary light and the secondary light, those ones of the LEDs whose primary lights having their chromaticities falling within a predetermined chromaticity range being classified as LEDs for use in a backlight of a liquid crystal display apparatus. The LED classification device calculates, for all of the LEDs to be classified, correction values for the chromaticities as obtained on the assumption that the primary lights have traveled through a color filter of the liquid crystal display apparatus, and correct chromaticities by subtracting the correction values from chromaticities obtained for all of the LEDs to be classified, respectively.